Infectious Disease Testing Market: USA, Europe, Japan--Sales Forecasts by Country, Strategic Profiles of Leading Suppliers, Emerging Tests, Technology Trends, Instrumentation Review

Publisher Name :
Date: 30-Sep-2016
No. of pages: 950

This new 950-page report from VPGMarketResearch provides analysis of the global infectious disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers.

The report presents:

  • Estimated numbers of infectious disease testing laboratories, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, U.K. and U.S.
  • Comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 100 infectious diseases and viruses, including scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs, and listings of companies developing or marketing new technologies and products.
  • Major analyzers used for infectious disease testing, including their features and operating characteristics.
  • Analyses of current and emerging technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scattering, chromatography and several others.
  • Strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. 
  •              Contains 950 pages and 34 tables

    Infectious Disease Testing Market: USA, Europe, Japan--Sales Forecasts by Country, Strategic Profiles of Leading Suppliers, Emerging Tests, Technology Trends, Instrumentation Review

    Table of Contents

    I. Worldwide Business Environment
    II. Worldwide Market Structure
    III. Worldwide Market Size and Growth
    IV. Major Infectious Disease Tests
    1. AIDS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    2. Adenovirus a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    d. Adeno-Associated Viruses(AAV)
    3. Aeromonas
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    4. Anthrax/Bacillus Anthracis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    5. Arboviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    6. Babesiosis
    a. Background
    7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    8. Blastocystis Hominis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    9. Brucella
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    10. Campylobacter a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    11. Candida a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    12. Chagas Disease
    a. Background
    13. Chancroid a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    14. Chlamydia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    15. Clostridium Difficile
    a. Background
    b. Diagnostic Tests
    c. Drugs and Vaccines
    16. Coronaviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    17. Coxsackieviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    18. Creutzfeldt-Jakob's Disease
    a. Background
    b. Diagnostic Tests
    c. Vaccines
    19. Cryptosporidium Parvum
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    20. Cyclospora Cayetanensis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    21. Cytomegalovirus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    22. Ebola Virus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    23. E. Coli
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    24. EchoVirus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    25. Encephalitis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    26. Enteroviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    27. Epstein-Barr Virus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    28. Giardia Lamblia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    29. Gonorrhea
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    30. Granuloma Inguinale
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    31. Hantavirus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    32. Helicobacter Pylori
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    33. Hepatitis
    a. Background
    b. Hepatitis A
    c. Hepatitis B
    d. Hepatitis C
    e. Vaccines and Drugs
    34. Herpes Simplex Virus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    35. Human Herpes Virus-6 (HHV-6)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    36. Influenza Viruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    37. Legionella
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    38. Lyme Disease
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    39. Lymphogranuloma Venereum (LGV)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    40. Malaria
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    41. Measles (Rubeola)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    42. Meningitis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    43. Microsporidium
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    44. Mononucleosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    45. Mumps
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    46. Mycoplasma
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    47. Papillomaviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    48. Parvovirus B19
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    49. Pneumonia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    50. Polyomaviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    51. Pseudomonas Aeruginosa
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    52. Rabies a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    53. Respiratory Syncytial Virus (RSV)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    54. RhinoViruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    55. RotaVirus (REOVIRUS)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    56. Rubella(MEASLES)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    57. Salmonellosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    58. Septicemia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    59. Shigellosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    60. Staphylococcus Aureus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    61. Streptococci
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    62. Syphilis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    63. Toxoplasmosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    64. Trichomonas Vaginalis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    65. Tuberculosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    66. Vibrio
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    67. West Nile Virus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    68. Yersina
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    V. Instrumentation Review: Leading analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Orth-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and other suppliers
    VI. Current and Emerging Technologies
    1. Molecular Diagnostics
    a. Technology Overview
    b. Amplification Methods
    Polymerase Chain Reaction
    - Temperature Cyclers
    - PCR Variations
    Immuno-PCR
    QC-PCR
    DAP-PCR
    Ligase Chain Reaction
    Branched DNA
    Q-Beta Replicase
    Nucleic-Acid Sequence-Based
    Strand Displacement Activation
    2. Monoclonal Antibodies
    3. Immunoassays
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    Dot Immunobinding Assays
    Capillary Immunoassays
    Particle-Membrane Capture Immunoassays
    Enzyme Amplification
    c. Fluorescent Immunoassays
    Fluorescence Polarization
    Time-Resolved Pulse Fluorescence
    d. Luminescence
    Chemiluminescence
    Bioluminescence
    e. Latex Agglutination
    f. Immunoprecipitation
    4. Differential Light Scattering
    5. IT
    6. Artificial Intelligence
    7. Liposomes
    8. Flow Cytometry
    9. Chromatography
    10. MRI
    11. Gel Microdroplets
    12. Other
    VII. Competitive Profiles
    - Abbott
    - Affymetrix
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - bioMerieux
    - Bio-Rad
    - Cepheid
    - Diamedix
    - DiaSorin
    - Eiken Chemical
    - Elitech Group
    - Enzo Biochem
    - Fujirebio
    - Grifols
    - Hologic/Gen-Probe
    - ID Biomedical/GSK
    - Kreatech/Leica
    - Lonza
    - Ortho-Clinical Diagnostics
    - Qiagen
    - Roche
    - Scienion
    - Sequenom
    - SeraCare
    - Siemens
    - Takara Bio
    - Thermo Fisher
    - Wallac/PE
    - Wako

    List of Tables

    Major Companies Developing or Marketing AIDS Tests
    Major Companies Developing or Marketing Adenovirus Tests
    Major Companies Developing or Marketing Bartonella Tests
    Major Companies Developing or Marketing Campylobacter Tests
    Major Companies Developing or Marketing Candida Tests
    Major Companies Developing or Marketing Chlamydia Tests
    Major Companies Developing or Marketing Clostridium Tests
    Major Companies Developing or Marketing Coronavirus Tests
    Major Companies Developing or Marketing Cryptosporidium Tests
    Major Companies Developing or Marketing CMV Tests
    Major Companies Developing or Marketing Echovirus Tests
    Major Companies Developing or Marketing Enterovirus Tests
    Major Companies Developing or Marketing EBV Tests
    Major Companies Developing or Marketing Giardia Tests
    Major Companies Developing or Marketing Gonorrhea Tests
    Major Companies Developing or Marketing Hantavirus Tests
    Major Companies Developing or Marketing Helicobacter Pylori Tests
    Major Companies Developing or Marketing Hepatitis Tests
    Major Companies Developing or Marketing Herpes Tests
    Major Companies Developing or Marketing Influenza Tests
    Major Companies Developing or Marketing Legionella Tests
    Major Companies Developing or Marketing Lyme Disease Tests
    Major Companies Developing or Marketing Lymphogranuloma Tests
    Major Companies Developing or Marketing Malaria Tests
    Major Companies Developing or Marketing Measles Tests
    Major Companies Developing or Marketing Meningitis Tests
    Major Companies Developing or Marketing Microsporidium Tests
    Major Companies Developing or Marketing Mononucleosis Tests
    Major Companies Developing or Marketing Mumps Tests
    Major Companies Developing or Marketing Mycoplasma Tests
    Major Companies Developing or Marketing Papilloma Virus Tests
    Major Companies Developing or Marketing Parvovirus Tests
    Major Companies Developing or Marketing Pneumonia Tests
    Major Companies Developing or Marketing RSV Tests
    Major Companies Developing or Marketing Rotavirus Tests
    Major Companies Developing or Marketing Rubella Tests
    Major Companies Developing or Marketing Salmonella Tests
    Major Companies Developing or Marketing Septicemia Tests
    Major Companies Developing or Marketing Shigella Tests
    Major Companies Developing or Marketing Staphylococci Tests
    Major Companies Developing or Marketing Streptococci Tests
    Major Companies Developing or Marketing Syphilis Tests
    Major Companies Developing or Marketing Toxoplasmosis Tests
    Major Companies Developing or Marketing Trichomonas Tests
    Major Companies Developing or Marketing Tuberculosis Tests
    Major Companies Developing or Marketing West Nile Tests
    Major Companies Developing or Marketing Yersinia Tests
    Table 1: Laboratories Performing Infectious Disease Tests by Country
    Table 2: Total Infectious Disease Test Volume Forecast by Country
    Table 3: Total Infectious Disease Diagnostics Market Forecast by Country
  • POC Lipid Testing Market, 2021
    Published: 22-Sep-2017        Price: US 4350 Onwards        Pages: 340
    This new 340-page report from LeadingMarketResearch.com contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market.Ration......
  • Global Rapid Influenza Diagnostic Tests Sales Market Report 2017
    Published: 21-Sep-2017        Price: US 4000 Onwards        Pages: 116
    In this report, the global Rapid Influenza Diagnostic Tests market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Rapid Influenza Diagnostic Tests for these regions, from 2012 to 2022 (forecast), covering - United States - China......
  • Global POC HbA1C Testing Market 2017-2021
    Published: 19-Sep-2017        Price: US 3500 Onwards        Pages: 84
    POC diagnostic tests help in reducing the time between diagnosis and treatment of a disease. These tests include enzyme-linked immunosorbent assay (ELISA), agglutination tests, and lateral flow immunochromatography. Hemoglobin (Hb) is the oxygen-carrying pigment which provides red color to the blood. The measurement of HbA1c helps in monitoring the average blood sugar level. POC testing kits for HbA1c has been introduced in the market for efficient and faster detection of diabetes and pre-dia......
  • Infectious Diseases 2021: Supplier Shares and Market Segment Forecasts by Test--A Rapidly Growing and Challenging Market Facing Suppliers--Technological Breakthroughs, Emerging Tests, Competitive Intelligence
    Published: 14-Sep-2017        Price: US 24500 Onwards        Pages: 1900
    Complete report $24,500. DataPack (test volumes, sales forecasts, supplier shares) $15,900. LeadingMarketResearch.com's new report is a seven-countrystrategic analysis of major business opportunities emerging in the infectious disease testing market during the nextfive years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Japan, UK) and Japan; reviews current and emerging assays; analyzes potential ......
  • Infectious Disease Molecular Diagnostics Market 2021: Suppliers Shares by Test, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
    Published: 14-Sep-2017        Price: US 19500 Onwards        Pages: 775
    Complete report $19,500. DataPack (test volumes, sales forecasts, supplier shares) $12,500. The report is available by country, section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new seven-country study from LeadingMarketResearchcontains 775 pages, 73 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in......
  • Europe Infectious Disease Molecular Diagnostics Market 2021: Suppliers Shares by Test, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
    Published: 14-Sep-2017        Price: US 11800 Onwards        Pages: 700
    Complete report $11,800. DataPack (test volumes, sales forecasts, supplier shares) $7,700. The report is available by country, section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new five-country study from LeadingMarketResearchcontains 700 pages, 54 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infe......
  • France Infectious Disease Molecular Diagnostics Market 2021: Suppliers Shares by Test, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
    Published: 14-Sep-2017        Price: US 4350 Onwards        Pages: 615
    Complete report $4,350. DataPack (test volumes, sales forecasts, supplier shares) $2,800. The reportis available by section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new study from LeadingMarketResearchcontains 615 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular......
  • Germany Infectious Disease Molecular Diagnostics Market 2021: Suppliers Shares by Test, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
    Published: 14-Sep-2017        Price: US 4350 Onwards        Pages: 615
    Complete report $4,350. DataPack (test volumes, sales forecasts, supplier shares) $2,800. The reportis available by section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new study from LeadingMarketResearchcontains 615 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular......
  • Italy Infectious Disease Molecular Diagnostics Market 2021: Suppliers Shares by Test, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
    Published: 14-Sep-2017        Price: US 4350 Onwards        Pages: 610
    Complete report $4,350. DataPack (test volumes, sales forecasts, supplier shares) $2,800. The reportis available by section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new study from LeadingMarketResearchcontains 610 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs